Health ❯ Healthcare ❯ Clinical Trials

Drug Approval

FDA FDA Approval FDA Regulations FDA Approvals Regulatory Affairs Anvisa NHS Treatments Semaglutide EMA Eli Lilly

FDA Approves Daraxonrasib for Advanced Pancreatic Cancer

The move could expand treatment options for people with RAS‑driven tumours.

FDA Grants Accelerated Approval for RP1 (Tudriqev) With Nivolumab in Advanced Melanoma

FDA Approves Lipfendra, First Oral PCSK9 Pill for High LDL Cholesterol

FDA Approves First Oral PCSK9 Pill, Merck’s Lipfendra

FDA Approves Lipfendra, First Oral PCSK9 Pill to Lower LDL

FDA Approves First Oral PCSK9 Pill, Merck’s Lipfendra

FDA Approves Utebzi as First Oral Carbapenem for Complicated UTIs

NHS Approves First New Ovarian Cancer Drug in 20 Years

FDA Expands Afrezza Inhaled Insulin Approval to Children Ages 6 and Up

Autism Leucovorin Prescriptions Jump 2,000% After Media and White House Promotion

FDA Grants Accelerated Approval to First BCL2 Drug for Relapsed Mantle Cell Lymphoma

Lilly Launches First Amyloid-Targeting Alzheimer’s Drug in India at Rs 91,688 a Dose

FDA Approves Bizengri for NRG1 Fusion Cholangiocarcinoma Under Accelerated Pathway

FDA Expands Tzield Use to Delay Type 1 Diabetes in Children Ages 1 to 7

Anvisa Approves Mounjaro for Type 2 Diabetes in Children Ages 10–17

NICE Recommends Zanidatamab for NHS Use in HER2-Positive Biliary Tract Cancer

FDA Grants Accelerated Approval to Lilly’s Oral Weight-Loss Pill Foundayo

FDA Approves Awiqli, First Once-Weekly Basal Insulin for Type 2 Diabetes

FDA Approves First Glucocorticoid Receptor Blocker for Platinum-Resistant Ovarian Cancer

FDA Approves Nivolumab Plus AVD as First-Line Therapy for Advanced Hodgkin Lymphoma